Feminine Hygiene Market to Perceive Momentous Accruals with a hefty CAGR By 2024

 Feminine Hygiene Market Analysis

The global feminine hygiene market has become mainstream witnessing an increased uptake and hence sales of feminine care products. Rising awareness and consumer preference for the benefits of these products are the major feminine hygiene market trends. The market has been witnessing remarkable growth over the past few years and is expected to continue further with the same trends.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/7986 

According to Market Research Future (MRFR), the global feminine hygiene product market worth had reached USD 21.96 BN in 2018, which is estimated to appreciate at 7.2% CAGR during the forecast period (2019-2024). Initiatives undertaken by the governments and NGOs aiming to establish awareness for women’s health & hygiene are favoring the market growth extensively.

Also, factors such as the increasing disposable income and the emergence of low-cost feminine hygiene products are excellently driving the growth of the market. Growing awareness of female health & wellness would continue to boost market growth over the review period. Furthermore, augmenting demand for feminine hygiene products such as tampons and panty liners in developing countries is anticipated to influence the growth of the market.

Conversely, after use effects triggered by the chemicals & bleaching agents used in the various women hygiene products such as allergy cases are anticipated to hamper revenue growth of the global market. Sometimes, these products can initiate a number of other side effects, including diarrhea, vomiting, low blood pressure, dizziness, rashes, and high fever. Awareness of these effects is affecting the growth of the market ato a great deal. Also, the high cost of these feminine hygiene products restricts market growth, especially in under-developed regions. 

Feminine Hygiene Market – Segmentations

The report is segmented into three market dynamics.

By Product Type: Tampons, Panty Liners, Sanitary Napkins/Pads, Feminine Hygiene Wash, Menstrual Cups, and others.

By Distribution Channel: Retail Pharmacies, Supermarket & Department Stores, Online Retail Stores, and others.

By Regions: Asia Pacific, North America, Europe, and the Rest-of-the-World. 

Global Feminine Hygiene Market – Geographical Analysis

The Asia Pacific region leads the global feminine hygiene market. The largest market share attributes to the growing awareness and expenditures for women’s health & wellness, especially in countries such as China and India. This has led to raising the sales of quality women’s hygiene products. Initiatives and funding by government and private organizations are playing a major role in spreading awareness about feminine hygiene products.

North America is anticipated to hold the second position in the global feminine hygiene market. Factors such as the quality lifestyle led by the high per capita income drive the market growth. Besides, the high penetration of feminine hygiene products such as tampons, panty liners, and internal cleansers due to the increasing numbers of working women supports regional market growth. Also, increasing demand by women for organic and biodegradable products fuels the feminine hygiene market size in North America.

Europe demonstrates a considerable amount of increase in the global feminine hygiene market share. The market growth is due to factors such as rapid urbanization, easy access to feminine hygiene products, growing disposable income, and increasing spending on menstrual products. Also, well-spread awareness of feminine hygiene plays a causal role in the development of the market. Besides, the presence of many players, increasing expenditures for health & wellness are a few of the significant factors propelling the growth of the European feminine hygiene market. 

Feminine Hygiene Market – Competitive Landscape

Widely expanded, the global feminine hygiene market appears to be moderately competitive with the handful of players operating in the market. Product precision, pricing, versatility, and reliability determine the competitive strength of these players. They compete with each other on product differentiation, portfolio, and pricing. These players have opted for online channels and digital marketing to create their niche. Online channels offer privacy to users, with consumers choosing to buy these products at their discretion.

Feminine Hygiene Market Major Players: 

Players active in the global feminine hygiene market include Procter and Gamble, Edgewell Personal Care, Unicharm Corporation, Kimberly-Clark Corporation, Lil-Lets Group Ltd, Svenska Cellulosa Aktiebolaget SCA, Ontex International, Johnson & Johnson, Kao Corporation, and Natracare LLC, among others.

Feminine Hygiene Industry/Innovation/ Related News:

April 23, 2020 --- Woolchemy (New Zealand), a leading producer of intelligent eco-logical textiles and wool-based sustainable nonwovens, launched a wool-based acquisition distribution layer for single-use hygiene products. Woolchemy has developed two patent-pending wool absorbency technologies called neweZorb and neweFlex. neweZorb is biodegradable & compostable, renewable & sustainable, washable & disposable, and contains no chemical residues. neweFlex is engineered to absorb & repel moisture, which is why it is called a one-way-moisture-transfer-layer that keeps the skin dry & redistributes fluids to the absorbent core.

Obtain Premium Research Report Details @ https://www.marketresearchfuture.com/reports/feminine-hygiene-market-7986

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

Digital Radiology Devices Market - Factors Driving Growth Post 2024

 The report takes a look at major developments within the global Digital Radiology Devices Market amidst the pandemic of the COVID-19 virus. It offers a perspective on the economic scenario and efforts to be taken post the passing of the pandemic.

Digital Radiology Devices Market Overview 

The most immediate benefit of digital radiology devices is that they allow the deployment of a completely digital image data management and communication system, with electronically stored and accessible photographs at any moment. Thus, the delivery of images in medical facilities through internet-based technology can be done electronically without including the risk of losing data. Certain benefits include better dosage performance, patient throughput, and a wider dynamic range of automated sensors with potential elimination of patient x-ray exposure. 

Get a FREE Sample with Complete TOC by Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/7973

Since the devices can be placed on desks, one benefit of these devices is better clinical utility. To date, only a handful clinical trials have been performed with flat-panel devices based on selenium. In addition, the higher DQE values of most digital detectors relative to screen-film hybrids indicate that digital devices have the ability to substantially minimize patient exposure without even a loss in image quality in addition to offering improved quality. Efforts are being made to improve both optical x-ray quality and intensity. 

The global demand for automated radiology tools anticipated a substantial growth over the forecast period. The had a valuation of USD 8146.54 million in 2018 and is projected to rise throughout the forecast period at a CAGR of 10.8 percent. Digital radiology device is one of the market's main segments, and is anticipated to expand at the highest growth rate. The key factors driving overall growth typically involve: increased growth in medical device technology innovation, increased economic development, increased demand for portable imaging equipment, and increased digital radiology uses. 

Digital Radiology Devices Market Key Players

Some of the prominent players in the global digital radiology devices market are Agfa-Gevaert Group, Canon Inc, Carestream Health Inc, Fujifilm Holdings Corporation, General Electric Company, Hitachi, Ltd., Konica Minolta, Inc, Koninklijke Philips N.V., Siemens, Varian Medical Systems, Inc, Shimadzu Corporation, Hologic, Nucleotech Medical Systems International Limited, Protec GmbH & Co. KG

Digital Radiology Devices Market Segmentation 

The study on the demand for digital radiology devices market discusses the business structure focused on all of the key market categories. This segment based research, along with regional study, helps understand the underlying facets of the market. The report provided sufficient data and analysis on each of the segments of the market with a view to presenting an accurate and thorough overview of the entire market. The report also provides forecasts on each of the local and regional segments. On the basis of type, the global market for digital radiology devices market has been segmented into Portable Digital Radiology System and Stationary Digital Radiology Systems. Based on methods, the market is further segmented into direct radiography and computed radiology. On the basis of application, the market is segmented into Orthopedic Imaging, Chest Imaging, Dental Imaging, Cardiovascular Imaging, and Mammography Imaging. And by end user, the market has been segmented into Diagnostic Centers and Hospitals & Clinics. 

Digital Radiology Devices Market Regional Overview 

Asia-Pacific seems to be the fastest rising market for digital radiology devices due to the rising investment in new imaging devices, the emergence of a large pool of patients and the rapid development of the technology. Furthermore, due to increasingly rising economies and growing supply of funds, and rising demand for advanced radiology products, many companies are seeking to expand their presence in the region. The digital radiology devices industry in the Middle East and Africa is projected to expand at a steady rate. Europe is expected to maintain the second-largest spot onto the worldwide market for digital radiology devices. 

Digital Radiology Devices Industry News 

An academic medical facility, Virginia Commonwealth University (VCU) Health has built the DRX-Revolution Nano as a unit entirely dedicated to the NICU, in an attempt to prevent the necessary spread of adult patient-acquired outbreak on other hospital floors. The DRX-Revolution Nano Handheld X-ray device from Carestream Health helps the youngest patients of Virginia Commonwealth University Health System remain healthy to its Intensive care Unit (NICU).

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/digital-radiology-devices-market-7973   

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

EClinical Solutions Market to Perceive Momentous Accruals with a hefty CAGR By 2023

 The Global eClinical Solutions Market is expected to register a CAGR of 12.24% to reach USD 9434.57 million by 2023.

eClinical solutions combine clinical technology and expertise and are used to improve the clinical development process through data management and data analysis. Major factors characterizing the market growth are increasing R&D activities by biopharmaceutical and pharmaceutical companies, growing expenditure on the development of clinical trials, rising burden of chronic diseases, and increased adoption of smart devices for healthcare management.  

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/2294 

Market Dynamics

The global eClinical solutions market has been largely benefited by the research and development activities conducted by pharmaceutical companies. Increasing healthcare expenditure on clinical trials is also responsible for the growth of the market during the forecast period. Advanced eClinical technologies have helped to manage such data requirements with reduced development costs and quick decisions prospective for new product developments and launches, thereby increasing the efficacy of the clinical trial process. Moreover, t increasing burden of chronic diseases such as cardiovascular diseases, cancer, diabetes, and chronic respiratory diseases is further expected to boost the growth of the global eClinical solutions market during the review period.   

Segmentation

The Clinical Data Management System (CDMS) segment is expected to lead the market and register a substantial CAGR to reach USD 2579 million by the end of 2023. CDMS is considered to be the most important part of eClinical solutions. CDMS is a tool used in clinical research to manage and store the data of clinical trials. However, the electronic clinical outcome assessment (eCOA) segment is projected to exhibit the highest CAGR of 14.98% from 2018 to 2023. The increasing demand for electronic clinical outcome assessment is driving the growth of the segment.

Key Players

The prominent players in the global eClinical solutions market are ERT Clinical, PAREXEL International Corporation, BioClinica, Inc., CRF Health, Oracle Corporation, DATATRAK International, Inc., Merge Healthcare Inc, Medidata Solutions, Inc., Omnicomm Systems, Inc. and MaxisIT.

The players operating in the global eClinical Solutions market are focusing on product launches, along with expanding their global footprints by entering untapped markets.   

Regional Analysis

The Americas accounted for the largest market share of 47.99% in 2017, and the regional market is projected to register a CAGR of 12.41 % during the forecast period. The US is one of the leading markets in the region, accounting for the largest market share during the review period. However, the Canada market is projected to exhibit the highest growth rate of 9.98% during the forecast period from 2018 to 2023.  

The Asia-Pacific market is likely to show significant growth during the forecast period. Increasing outsourcing of clinical trials and availability of diverse patient population are the major drivers for market growth. India is the fastest growing region owing to its large geriatric population, which is driving the growth of the eClinical solutions market in the region. Japan is the major contributor to the growth of the regional market, followed by China.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/eclinical-solution-market-2294  

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

PEGylated Drugs Market Key Manufactures Shares, Analysis And Forecasts Till 2025

 An expert on premium research reports, Market Research Future has added a report titled “Global PEGylated drugs Market 2025” to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe.

PEGylated Drugs Market Analysis

The global PEGylated drugs market is expected to exhibit a solid 5.53% CAGR over the forecast period from 2019 to 2025, according to the latest research report from Market Research Future (MRFR). The global PEGylated drugs market is expected to reach a valuation of USD 13.5 billion by 2025. The major drivers and restraints affecting the global PEGylated drugs market are profiled in the report to provide readers with a clear overview of the major factors determining the movement of the market. This provides readers with a clear overview of the movement of the market. The historical growth trajectory of the global PEGylated drugs market is also assessed in the report, along with forecasts for the market’s movement over the forecast period.

Also Read :https://www.medgadget.com/2020/06/coronavirus-covid-19-impact-on-pegylated-drugs-market-2020-global-industry-analysis-merger-demand-overview-growth-rate-swot-analysis-top-leaders-forecast-to-2025.html

PEGylation is the addition of a polyethylene glycol polymer to bioactive molecules such as proteins, peptides, enzymes, and others. The addition of PEG increases the efficacy of the bioactive molecules by making the molecule less detectable by the body’s immune system. It also increases the size of the molecule in a solution, increasing the amount of time before the renal system detects and excretes it. Hydrophobic drugs and molecules are also made water-soluble by PEGylation, which is a key factor driving the global PEGylated drugs market. Growing awareness about these benefits of PEGylation is likely to drive the global PEGylated drugs market.

Due to the growing awareness of the benefits of PEGylation, many leading companies are investing in PEGylation, leading to a more widespread interest in the process in the healthcare and life sciences sectors. Due to this significant investment, many companies have PEGylated molecules in the pipeline. Several PEGylated drugs have received FDA clearance and many are in the testing phase currently. On the other hand, adverse reactions to PEGylated drugs and consequent recalls are likely to be the major restraint on the global PEGylated drugs market over the forecast period.

PEGylated Drugs Market Competitive Leaderboard:

Leading players in the global PEGylated drugs market include Bayer AG, Takeda Pharmaceutical Company Ltd., Merck & Co. Inc., AstraZeneca, Amgen Inc., UCB SA, Novo Nordisk A/S, Pfizer Inc., F. Hoffman-La Roche Ltd., and Horizon Therapeutics plc. Leading players in the global PEGylated drugs market are focusing on product launches at the moment, as the regulatory environment is ripe for new product launches.

PEGylated Drugs Market Segmentation:

The global PEGylated drugs market is segmented on the basis of molecule, indication, and region.

By molecule, the global PEGylated drugs market is segmented into proteins, FAB fragments, enzyme, aptamers, and others. The proteins segment holds a dominant 64.8% share in the global PEGylated drugs market and is likely to remain in the driving seat over the forecast period due to the growing interest in PEGylated proteins.

By molecule, the global PEGylated drugs market is segmented into cancer, gout, hemophilia, hepatitis, and others.

PEGylated Drugs Market Regional Analysis:

The Americas hold a dominant share of 65.73% share in the global PEGylated drugs market. The strong position of the healthcare and life sciences sectors in North America is the major driver for the PEGylated drugs market in the Americas. Growing investment in PEGylated drugs is likely to result in steady growth of the market in the region over the forecast period. North America, led by the U.S., is the dominant regional market within the Americas and is likely to remain the dominant force over the forecast period. The rising prevalence of cancer in the region and the growing demand for effective drugs against the same is likely to be a major driver for the PEGylated drugs market in North America. The rising prevalence of hemophilia is also a major driver for the PEGylated drugs market.

Europe holds the second largest share in the global PEGylated drugs market. The rising occurrence of cancer in Europe is the major driver for the global PEGylated drugs market. Western Europe, comprising France, the UK, Germany, etc. is the dominant regional segment within Europe.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/pegylated-drugs-market-8436 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

Worldwide Metabolomics Services Market 2020 Synopsis With Leading Players, Industry Growth Factor Foresight By 2025

 This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Global Metabolomics Services Market over the forecast period.

According to Market Research Future (MRFR), metabolomics services market is expected to register a CAGR of 7.77% and estimated to reach USD 16,291.0 million by 2025. Metaboliomics can be described as the study and analysis of biochemical processes involving intermediates and by-products of metabolic activities. Such products are known as metabolomes, which constitute the cluster of all metabolites involved in various reactions in the organism, including signaling molecules, secondary metabolites, metabolic intermediates, and hormones.

Also Read : https://www.medgadget.com/2020/04/metabolomics-services-market-is-projected-to-register-cagr-of-7-77-by-2025-says-mrfr.html 

Metabolomics Services Market DynamicsMetabolite analysis is widely used for early diagnosis of various diseases such as cancer, neurological disorders, heart disease, and others. Among the various clinical conditions, cancer is the largest contributor to the demand for metabolomics services market. It is primarily attributed to the global rise in cancer incidence and increasing oncological research activities. According to the World Health Organization (WHO), cancer was the second leading cause of deaths worldwide and responsible for 8.8 million deaths in 2015. According to the National Cancer Institute, an estimated 1,735,350 new cases of cancer have been diagnosed in the US in 2018. The global metabolomics services market is driven by a rise in the use of metabolomics in precision medicine and the advent of diagnostic testing for the diagnosis of chronic diseases. Moreover, technological developments in analytical techniques and an increase in R&D expenditure are expected to fuel market growth.

Metabolomics Services Market Segmentation

The global demand for metabolomics services is segmented into products and services, and applications.

The demand for baby products and services has been segmented into chromatography, metabolic bioinformatics services and mass spectrometry.

Based on the application, the global market for metabolomics services has been segmented into the biomedical and pharmaceutical, agriculture, and food industries.

Metabolomics Services Market Regional Analysis

The global metabolomics services market, based on region, is divided into the Americas, Europe, the Asia Pacific, and the Middle East & Africa.

The Americas are expected to have the largest share of the global market in services to metabolomics. Americas development can be related due to the increasing prevalence of cancer and cardiovascular diseases. It is projected that 1,762,450 new cancer cases will be diagnosed in the US in 2019, according to the American Cancer Society, Inc. Due to estimates from the National Institutes of Health for 2018, the number of cancer cases and the number of patients will both rise to 23.6 million by 2030.

Europe is expected to have the second-largest market share in the forecast period. The European market for metabolic services is further divided into Western Europe and Eastern Europe. Western Europe is further divided into Germany, the United Kingdom, Italy, Spain, France, and the rest of Western Europe. The factors responsible for the growth of the market in this area are the presence of a large number of medical device companies, increased spending on health care, and innovation in medical devices to improve quality of life.

The Asia Pacific is expected to be the fastest-growing market due to the evolving healthcare infrastructure, increasing numbers of R&D organizations and rising disposable revenue. In addition, the growth of research and development centers and the entry of top companies in developed countries are boosting market growth in this region.

Due to factors such as low per capita income, the Middle East & Africa are projected to show the least growth on the global metabolomics services sector, and lack of sufficient funding for healthcare infrastructure accounted for a comparatively smaller market share in 2018.

Metabolomics Services Market Key players

The Key Players in the global metabolomics services market are Waters (US), Agilent Technologies, Inc. (US), Bruker (US), TMIC (Canada), Thermo Fisher Scientific (US), Biocrates Life Sciences AG (Austria), Creative Proteomics (US), Metabolon, INC (US), Human Metabolome Technologies America Inc (Japan), and Shimadzu Corporation (Japan). Innovation, product growth, and acquisition & mergers were some of the main strategies pursued by players operating on the global metabolomics services market.

Metabolomics Services Industry News

Bruker collaborated with Research SL in December 2018 to advance chemistry software that handles spectroscopic data, and extracts and manages chemical information from a variety of analytical techniques, such as NMR and mass spectrometry.

In June 2019, Thermo Fisher Scientific, a prominent developer of mass spectrometry software based in Bratislava, Slovakia, acquired HighChem, Ltd. HighChem software tools are used in the pharmaceutical and metabolomic laboratories to analyze complex data and to classify small molecules.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/metabolomics-services-market-8435 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Pain Relief Medication Market Production, Capacity, Revenue, Price, Gross Margin Analysis And Forecast 2020-2025

 Market Research Future with their unique quality of simplifying the market research study, announces a deep study report on “Pain Relief Medication Market Research Report – Forecast to 2025” Gives industry size, top players and worldwide demand

Pain Relief Medication Market Overview:

Global report on the pain relief medication market reveals the potentials to achieve 4.73% CAGR within a period of 2019 to 2025, which has been defined as the forecast period by Market Research Future (MRFR).

The report contains factors like increasing expenditure capacity of the normal human beings, better inclusion in hospitals and various treatments, hike in research funding, better drug development technology using AI and other advanced technologies, hike in clearance rate, government support, and others that can ensure a rise in returns for the pain relief medication market.Also Read :  https://www.medgadget.com/2020/03/pain-relief-medication-industry-2020-increasing-drug-research-procedures-to-influence-pain-relief-medication-market-growth.html
Pain Relief Medication Market Segmentation:

The global study of the pain relief medication market can be studied by having a strong foundation of details from segments like drug class, indication, and distribution channel. Their insights would help in developing tactical moves and enhance market profit.

By drug class, the study on the pain relief medication market can be segmented into opioids, COX-2 inhibitors, nonsteroidal anti-inflammatory drugs, and others. The nonsteroidal anti-inflammatory drug segment would dominate as its inclusion is far better than others for its high efficacy rate. The opioids segment may turn out to be the fastest-growing as the awareness regarding its use is growing.

The global market study on pain relief medication can be segmented by indication into neuropathic pain, cancer pain, inflammatory conditions, musculoskeletal pain, and others. The cancer pain segment has the maximum market share. Recent market sales are showing a hike in the neuropathic pain segment due to a hike in rising economies.

By distribution channel, the pain relief medication market can be segmented into hospital & retail pharmacies and online pharmacies. The hospitals and retail pharmacies segment have the largest market share.

Pain Relief Medication Market Regional Analysis:

Global Pain Relief Medication Market, as discussed in the MRFR report, would see benefits from the Americas. This is primarily due to the rising concerns shown by companies in the region in terms of drug development. Hike in expenditure is boosting the process, and the market would favor all the moves by establishing procedures that would make the integration process of these drugs easier. Europe would develop similar strains using which the market would record high growth. France, Germany, the UK, Russia, Italy, and others are making substantial progress in the sector. They invest a notable amount of their budget in developing better infrastructure to assist various pharmaceutical companies in the manufacturing of these drugs.

The Asia Pacific region is getting acclaims as several regional companies from India, China, Japan, South Korea, and others are showing their keen interest in participating in the market. The massive population of the region would boost the regional market revenue. Also, various global brands are trying to explore the regional resource to expand their business, which might help the regional market outcome.

Pain Relief Medication Market Competitive Landscape:

The global pain relief medication market has a chance to benefit from strategic moves incorporated by several top-class companies like Allergan plc (Ireland), AbbVie Inc. (US), Bayer (Germany), Astellas Pharma Inc. (Japan), Boehringer Ingelheim International GmbH (Germany), Biogen Idec (US), GlaxoSmithKline (UK), Mallinckrodt Pharmaceuticals (UK), Bristol-Myers Squibb (US), Eli Lilly and Company (US), Pfizer, Inc. (the US), Sanofi (France), Purdue Pharma (US), and Teva Pharmaceutical Industries Ltd (Israel). The constant endeavor to set a firm foot in the market has led to the development of strategies that span across several pointers like mergers, collaborations, acquisitions, and others. Hike in research-related expenditure would also influence the market outcome.

Pain Relief Medication Industry News:

In March 2020, reports revealed that a shortage of raw materials of pain relief medication had been witnessed due to the global pandemic coronavirus. This has triggered a rise in the price of pain relief medication like Aspirin and all. In the UK, the price surged by 30% in some places. Individual drug makers are struggling to keep up with the pace of this change in the market.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/pain-relief-medication-market-8431 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

Worldwide Light Therapy Market Witness A Remarkable Growth Projected By 2025

 Recently MRFR, a leading market research firm collated a novel report on “Global Light Therapy Market Research Study” that gives comprehensive market overview about the current market dynamics with a focus on the worldwide market.

Light Therapy Market Overview

Global light therapy market is growing at a rapid pace, mainly due to the rising demand for non-invasive treatments. Applications of light therapy are increasing widely, comprising treatments of a myriad of diseases ranging from sun damage and acne to mTBT and skin cancer. Technological advances have offered some exciting possibilities to revolutionize the treatment procedures further. Resultantly, the light therapy market size is increasing year by year on a global platform.

Also Read : https://www.medgadget.com/2020/03/global-light-therapy-market-is-predominantly-led-by-the-rising-applications-of-the-light-therapy-mrfr-reveals-the-forecast-for-2019-2025.html 

According to Market Research Future (MRFR), the global light therapy market is poised to touch a valuation of approximately USD 1,112.16 MN by 2025, registering 5.1% CAGR during the review period (2019-2025). Rising numbers of dermatological disorder cases and psychological conditions are fueling the growth of the market. Also, the increasing adoption of light therapy to provide non-invasive yet hugely effective treatment methods push market growth.
Additionally, factors such as the rapid increase in population, urbanization, and global economy substantiate the growth of the market excellently. Growing prevalence of SAD (seasonal affective disorder) and improving reimbursement policies offered by health insurance providers to cancer, psoriasis, neonatal jaundice, and eczema patients boost the market growth. Increasing research & development investments made by industry players impacts the light therapy market growth.

On the other hand, side effects associated with the therapy, such as nausea, headache, eye pain, burning sensation, itching, and agitation, hampers the growth of the light therapy market. Also, lack of awareness about light therapy in developing regions impedes market growth severely. Nevertheless, rising government support to spread awareness about the treatment would support the light therapy market growth, commutatively.

Global Light Therapy Market – Segmentation

The analysis has been segmented into five major dynamics.

By Product: Light Box, Floor & Desk Lamps, Light Visor, Handheld Devices for Skin Treatment (HDST), Dawn Simulator, Light Therapy Bulbs, and others.

By Application: Psoriasis, Vitiligo, Eczema, Acne Vulgaris, Seasonal Affective Disorder (SAD), Sleeping Disorders, and others.

By Light Type: Blue Light, Red Light, White Light, and others.

By End-User: Homecare Settings, Dermatology Clinics, and others.

By Regions: Europe, Americas, Asia Pacific, Middle East & Africa, and Rest-of-the-World.

Beneficial effects of light therapy are well known, and today the light therapy is used to treat a myriad of conditions. Every light visible or non-visible (ultraviolet light) has specific effects on the human body. Different types of colored lights are used to treat depending upon the condition. For instance;

Blue Light: is increasingly used to treat a range of skin conditions. From sun damage and acne to mTBT and skin cancer. Also, the blue light exposure therapy is useful in healing people with mild traumatic brain injury, sleep disorders (insomnia).

Red Light: The red light therapy (RLT) is majorly used in joint pain and arthritis treatment. This therapeutic technique is also used to treat aging & trauma effects on the skin, such as wrinkles, scars, and incurable wounds, among other conditions. There are a whole lot of studies going on to find if RLT can be effective in treating muscle atrophy, slow wound healing, and bone density issues caused by weightlessness during space travel.

White Light: Bright/ white light therapy improves mood & energy by triggering the release of serotonin. It also improves sleep & focus by resetting circadian rhythm to its natural state & regulating melatonin. Hence, white light therapy is used to alleviate symptoms of Seasonal Affective Disorder (SAD), winter blues, and sleep disorders caused by an interruption in circadian rhythm.

Global Light Therapy Market – Regional Analysis

North America dominates the global light therapy market, heading with the rising demand for non-invasive procedures, and the increasing prevalence of dermatological disorders. High per capita healthcare expenditure is another key factor increasing the light therapy market share of the region. Moreover, the growing number of centers offering light therapy alongside the well-developed light therapy devices market in the region.

The US, backed by technological advances and finding support for R&D to bring improvements in the therapy, accounts for the major contributor to the market growth. Furthermore, the presence of the well-established players impacts the growth of the regional market, positively. The North American light therapy market is expected to create a large revenue pocket during the period 2019 – 2025.

Europe stands the second leading position in the global light therapy market. The market growth majorly attributes to increasing awareness about the benefits of light therapy devices. Besides, the rise in the adoption of light therapy devices alongside the resurging economy in the region fosters regional market growth.  Moreover, factors such as the technologically advanced facilities and increasing R&D funding support from the government contribute to the market growth in the region. The European light therapy market is estimated to expand at a phenomenal CAGR over the assessment period.

The Asia Pacific light therapy market is expected to perceive the fastest growth by 2025, registering a modest CAGR from 2019 to 2025. India and China lead the regional market growth due to the availability of cost-competitive treatment options. Moreover, spurring growth in the healthcare sector, huge population, and large unmet needs in the treatment of psychological conditions like depression and anxiety in the region provide impetus to the market growth.

Global Light Therapy Market – Competitive Analysis  

The light therapy market appears highly competitive and fragmented due to several well-established players forming a competitive landscape. Key Players are motivated to bring innovations in the therapy with minimum adverse effects, as well as to target emerging applications to leverage growth opportunities. They are focusing on R&D in order to develop the therapy further.  To drive market competition, players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. Multinational companies acquire small yet promising companies from emerging markets.

Light Therapy Market Major Players:

Players leading the light therapy market include Northern Light Technology (Canada), Beurer (Germany), Nature Bright (Taiwan), BioPhotas (US), Koninklijke Philips (Netherlands), Verilux (US), Chal-Tec GmbH (Germany), Lucimed SA (Belgium), Zepter International (Switzerland), and Lumie (UK), among others.

Industry/Innovation/Related News:

February 26, 2020 —- Researchers at the University of Sheffield announced that they have been successful at synthesizing a new compound that can improve the success rate of photodynamic therapy when treating cancer. The new compound uses sharp infrared light to damage cells directly and potentially improve the success rate of photodynamic therapy PDT. However, the problem with PDT is its penetration that does not always kill cells deep within a cancerous tumor, allowing tumors to grow back again. Sensitizer is a key compound in PDT, in which a light-sensitive medicine given to the patient. And when activated by light, it produces highly reactive oxygen-based species that kill the cancer cells.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/light-therapy-market-8366 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com